Flumazenil pretreatment in benzodiazepine-free patients: A novel method for managing declining ECT seizure quality

James Yi, Jonathan Torres, Yuval Azner, Punit Vaidya, Adam Schiavi, Irving M Reti

Research output: Contribution to journalArticle

Abstract

Objective: Seizure threshold increases with successive electroconvulsive therapy (ECT) treatments, which can be especially problematic when treating older patients who have higher seizure thresholds at baseline because ECT devices are limited by the amount of charge that can be delivered. Case Reports: We present a case series of 3 older patients who had long ECT courses that were complicated by inability to generate seizures, poor quality seizures, and inadequate clinical response despite established measures to lower seizure threshold including prehydration, hyperventilation, and minimizing methohexital dose using remifentanil. As preclinical studies show electroconvulsive seizure increases diazepam binding, we hypothesized that a contributor to declining seizure quality and inadequate ECT responsiveness in these individuals was enhanced benzodiazepine receptor function, although none of the 3 patients were taking benzodiazepines or any other anticonvulsant medication. Accordingly, we pretreated patients with flumazenil, a competitive inhibitor at the benzodiazepine-binding site, and observed improvement in seizure quality and clinical response. Conclusion: Flumazenil pretreatment of elderly ECT patients with declining seizure quality and inadequate clinical response in the setting of repeated treatments may represent a novel strategy for managing such patients. A clinical trial would be required to test this hypothesis.

Original languageEnglish (US)
Pages (from-to)185-189
Number of pages5
JournalJournal of ECT
Volume28
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

Flumazenil
Electroconvulsive Therapy
Benzodiazepines
Seizures
Methohexital
Hyperventilation
GABA-A Receptors
Diazepam
Anticonvulsants
Binding Sites
Clinical Trials
Equipment and Supplies

Keywords

  • ECT
  • elderly
  • flumazenil
  • major depressive disorder
  • seizure threshold

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience (miscellaneous)

Cite this

Flumazenil pretreatment in benzodiazepine-free patients : A novel method for managing declining ECT seizure quality. / Yi, James; Torres, Jonathan; Azner, Yuval; Vaidya, Punit; Schiavi, Adam; Reti, Irving M.

In: Journal of ECT, Vol. 28, No. 3, 09.2012, p. 185-189.

Research output: Contribution to journalArticle

@article{e365ef7c0506431fbf4231d6a4df2f0c,
title = "Flumazenil pretreatment in benzodiazepine-free patients: A novel method for managing declining ECT seizure quality",
abstract = "Objective: Seizure threshold increases with successive electroconvulsive therapy (ECT) treatments, which can be especially problematic when treating older patients who have higher seizure thresholds at baseline because ECT devices are limited by the amount of charge that can be delivered. Case Reports: We present a case series of 3 older patients who had long ECT courses that were complicated by inability to generate seizures, poor quality seizures, and inadequate clinical response despite established measures to lower seizure threshold including prehydration, hyperventilation, and minimizing methohexital dose using remifentanil. As preclinical studies show electroconvulsive seizure increases diazepam binding, we hypothesized that a contributor to declining seizure quality and inadequate ECT responsiveness in these individuals was enhanced benzodiazepine receptor function, although none of the 3 patients were taking benzodiazepines or any other anticonvulsant medication. Accordingly, we pretreated patients with flumazenil, a competitive inhibitor at the benzodiazepine-binding site, and observed improvement in seizure quality and clinical response. Conclusion: Flumazenil pretreatment of elderly ECT patients with declining seizure quality and inadequate clinical response in the setting of repeated treatments may represent a novel strategy for managing such patients. A clinical trial would be required to test this hypothesis.",
keywords = "ECT, elderly, flumazenil, major depressive disorder, seizure threshold",
author = "James Yi and Jonathan Torres and Yuval Azner and Punit Vaidya and Adam Schiavi and Reti, {Irving M}",
year = "2012",
month = "9",
doi = "10.1097/YCT.0b013e3182507752",
language = "English (US)",
volume = "28",
pages = "185--189",
journal = "Journal of ECT",
issn = "1095-0680",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Flumazenil pretreatment in benzodiazepine-free patients

T2 - A novel method for managing declining ECT seizure quality

AU - Yi, James

AU - Torres, Jonathan

AU - Azner, Yuval

AU - Vaidya, Punit

AU - Schiavi, Adam

AU - Reti, Irving M

PY - 2012/9

Y1 - 2012/9

N2 - Objective: Seizure threshold increases with successive electroconvulsive therapy (ECT) treatments, which can be especially problematic when treating older patients who have higher seizure thresholds at baseline because ECT devices are limited by the amount of charge that can be delivered. Case Reports: We present a case series of 3 older patients who had long ECT courses that were complicated by inability to generate seizures, poor quality seizures, and inadequate clinical response despite established measures to lower seizure threshold including prehydration, hyperventilation, and minimizing methohexital dose using remifentanil. As preclinical studies show electroconvulsive seizure increases diazepam binding, we hypothesized that a contributor to declining seizure quality and inadequate ECT responsiveness in these individuals was enhanced benzodiazepine receptor function, although none of the 3 patients were taking benzodiazepines or any other anticonvulsant medication. Accordingly, we pretreated patients with flumazenil, a competitive inhibitor at the benzodiazepine-binding site, and observed improvement in seizure quality and clinical response. Conclusion: Flumazenil pretreatment of elderly ECT patients with declining seizure quality and inadequate clinical response in the setting of repeated treatments may represent a novel strategy for managing such patients. A clinical trial would be required to test this hypothesis.

AB - Objective: Seizure threshold increases with successive electroconvulsive therapy (ECT) treatments, which can be especially problematic when treating older patients who have higher seizure thresholds at baseline because ECT devices are limited by the amount of charge that can be delivered. Case Reports: We present a case series of 3 older patients who had long ECT courses that were complicated by inability to generate seizures, poor quality seizures, and inadequate clinical response despite established measures to lower seizure threshold including prehydration, hyperventilation, and minimizing methohexital dose using remifentanil. As preclinical studies show electroconvulsive seizure increases diazepam binding, we hypothesized that a contributor to declining seizure quality and inadequate ECT responsiveness in these individuals was enhanced benzodiazepine receptor function, although none of the 3 patients were taking benzodiazepines or any other anticonvulsant medication. Accordingly, we pretreated patients with flumazenil, a competitive inhibitor at the benzodiazepine-binding site, and observed improvement in seizure quality and clinical response. Conclusion: Flumazenil pretreatment of elderly ECT patients with declining seizure quality and inadequate clinical response in the setting of repeated treatments may represent a novel strategy for managing such patients. A clinical trial would be required to test this hypothesis.

KW - ECT

KW - elderly

KW - flumazenil

KW - major depressive disorder

KW - seizure threshold

UR - http://www.scopus.com/inward/record.url?scp=84865746363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865746363&partnerID=8YFLogxK

U2 - 10.1097/YCT.0b013e3182507752

DO - 10.1097/YCT.0b013e3182507752

M3 - Article

C2 - 22513511

AN - SCOPUS:84865746363

VL - 28

SP - 185

EP - 189

JO - Journal of ECT

JF - Journal of ECT

SN - 1095-0680

IS - 3

ER -